Novo Nordisk
NVO
NVO
500 hedge funds and large institutions have $8.56B invested in Novo Nordisk in 2014 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 185 increasing their positions, 166 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% less call options, than puts
Call options by funds: $4.16M | Put options by funds: $4.29M
7% less capital invested
Capital invested by funds: $9.21B → $8.56B (-$646M)
28% less funds holding in top 10
Funds holding in top 10: 25 → 18 (-7)
Holders
500
Holding in Top 10
18
Calls
$4.16M
Puts
$4.29M
Top Buyers
| 1 | +$81.5M | |
| 2 | +$80.9M | |
| 3 | +$34.7M | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$32.7M |
| 5 |
Millennium Management
New York
|
+$24.6M |
Top Sellers
| 1 | -$172M | |
| 2 | -$47.3M | |
| 3 | -$34.2M | |
| 4 |
Renaissance Technologies
New York
|
-$20.8M |
| 5 |
GC
Gratry & Company
Beachwood,
Ohio
|
-$20.1M |